J. Bradley Layton

9.6k total citations · 2 hit papers
74 papers, 6.5k citations indexed

About

J. Bradley Layton is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Nephrology. According to data from OpenAlex, J. Bradley Layton has authored 74 papers receiving a total of 6.5k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Endocrinology, Diabetes and Metabolism, 12 papers in Surgery and 11 papers in Nephrology. Recurrent topics in J. Bradley Layton's work include Health Systems, Economic Evaluations, Quality of Life (6 papers), Hormonal and reproductive studies (6 papers) and Influenza Virus Research Studies (5 papers). J. Bradley Layton is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (6 papers), Hormonal and reproductive studies (6 papers) and Influenza Virus Research Studies (5 papers). J. Bradley Layton collaborates with scholars based in United States, Denmark and Germany. J. Bradley Layton's co-authors include Timothy B. Smith, Julianne Holt‐Lunstad, M. Alan Brookhart, Til Stürmer‎, Richard Wyss, Christoph Meier, Susan S. Jick, Julie L. Sharpless, Dongmei Li and Christian Fynbo Christiansen and has published in prestigious journals such as JAMA, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

J. Bradley Layton

66 papers receiving 6.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Social Relationships and Mortality Risk: A Meta-analytic Review

2010 4.6k citations J. Bradley Layton et al. profile →
Propensity Score Methods for Confounding Control in Nonexperimental Research

2013 451 citations M. Alan Brookhart, J. Bradley Layton et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J. Bradley Layton United States	21	2.2k	1.6k	1.4k	1.1k	762	74	6.5k
Karen A. Matthews United States	39	1.4k 0.7×	1.9k 1.1×	1.3k 0.9×	1.6k 1.4×	1.1k 1.5×	77	7.8k
Mai Stafford United Kingdom	50	3.0k 1.4×	2.7k 1.7×	954 0.7×	1.3k 1.1×	1.8k 2.4×	141	8.1k
Elaine A. Leventhal United States	41	1.1k 0.5×	1.9k 1.2×	1.0k 0.7×	933 0.8×	670 0.9×	72	6.9k
Nancy Perrin United States	51	1.5k 0.7×	2.3k 1.4×	858 0.6×	2.4k 2.1×	1.4k 1.8×	284	9.0k
Frank J. Penedo United States	47	818 0.4×	1.9k 1.2×	1.1k 0.7×	1.6k 1.4×	1.1k 1.5×	141	8.4k
Antti Uutela Finland	48	1.5k 0.7×	2.5k 1.5×	564 0.4×	983 0.9×	604 0.8×	160	7.2k
Ian Brissette United States	13	2.1k 1.0×	1.7k 1.1×	1.1k 0.8×	1.1k 1.0×	1.2k 1.6×	25	5.2k
Suzanne M. Skevington United Kingdom	46	1.5k 0.7×	2.2k 1.4×	1.6k 1.1×	2.2k 2.0×	1.0k 1.4×	128	9.5k
Judith A. Malmgren United States	25	2.1k 1.0×	2.1k 1.3×	1.4k 1.0×	2.4k 2.1×	1.7k 2.2×	58	10.8k
Marie Zins France	43	1.2k 0.5×	2.3k 1.4×	500 0.3×	609 0.5×	426 0.6×	327	7.2k

Countries citing papers authored by J. Bradley Layton

Since Specialization

Citations

This map shows the geographic impact of J. Bradley Layton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Bradley Layton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Bradley Layton more than expected).

Fields of papers citing papers by J. Bradley Layton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Bradley Layton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Bradley Layton. The network helps show where J. Bradley Layton may publish in the future.

Co-authorship network of co-authors of J. Bradley Layton

This figure shows the co-authorship network connecting the top 25 collaborators of J. Bradley Layton. A scholar is included among the top collaborators of J. Bradley Layton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Bradley Layton. J. Bradley Layton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kövesdy, Csaba P., Natalie Ebert, David Vizcaya, et al.. (2025). Change in Urine Albumin-Creatinine Ratio and Occurrence of Hyperkalemia in Patients Initiating Finerenone in the USA: A Cohort Study from the FOUNTAIN Platform. The Nephron journals/Nephron journals. 149(7). 371–383.

Layton, J. Bradley, Colin Anderson‐Smits, Hakan Ay, et al.. (2025). A Comparative Real‐World Study Evaluating the Safety of Immune Globulin Infusion (Human) 10% Solution and Other Intravenous Immunoglobulin Therapies for the Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy. Pharmacoepidemiology and Drug Safety. 34(3). e70124–e70124. 1 indexed citations

Pladevall, Manel, Catherine B. Johannes, J. Bradley Layton, et al.. (2024). FOUNTAIN: a modular research platform for integrated real-world evidence generation. BMC Medical Research Methodology. 24(1). 224–224. 4 indexed citations

Kövesdy, Csaba P., J. Bradley Layton, Gary C. Curhan, et al.. (2024). #2022 Clinical outcomes in US patients initiating finerenone – a report from the FOUNTAIN platform. Nephrology Dialysis Transplantation. 39(Supplement_1). 1 indexed citations

Johannes, Catherine B., Daniel C. Beachler, J. Bradley Layton, et al.. (2022). Post-Authorization Safety Study of Hospitalization for Acute Kidney Injury in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting. Drug Safety. 46(2). 157–174. 5 indexed citations

Danysh, Heather E., Catherine B. Johannes, Daniel C. Beachler, et al.. (2022). Post-Authorization Safety Studies of Acute Liver Injury and Severe Complications of Urinary Tract Infection in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting. Drug Safety. 46(2). 175–193. 2 indexed citations

Perez, Edith A., Chau T. Dang, Caleb Lee, et al.. (2022). Incidence of adverse events with therapies targeting HER2-positive metastatic breast cancer: a literature review. Breast Cancer Research and Treatment. 194(1). 1–11. 16 indexed citations

Forns, Joan, Heather E. Danysh, Lisa J. McQuay, et al.. (2022). Clinical outcomes and treatment patterns of older adults with dementia-related psychosis by dementia type in the United States. BMC Geriatrics. 22(1). 784–784. 7 indexed citations

Layton, J. Bradley, et al.. (2020). Heatwaves, medications, and heat-related hospitalization in older Medicare beneficiaries with chronic conditions. PLoS ONE. 15(12). e0243665–e0243665. 61 indexed citations

10.

Layton, J. Bradley, Anne M. Butler, M. Alan Brookhart, & Catherine A. Panozzo. (2019). Variation in rotavirus vaccination coding in state US Medicaid data. Vaccine. 37(22). 2892–2895. 3 indexed citations

11.

Adelborg, Kasper, et al.. (2019). Cardiovascular Outcomes and All-cause Mortality Following Measurement of Endogenous Testosterone Levels. The American Journal of Cardiology. 123(11). 1757–1764. 16 indexed citations

12.

Camplain, Ricky, Anna Kucharska‐Newton, Thomas C. Keyserling, et al.. (2018). Incidence of Heart Failure Observed in Emergency Departments, Ambulatory Clinics, and Hospitals. The American Journal of Cardiology. 121(11). 1328–1335. 13 indexed citations

13.

Layton, J. Bradley, Anne M. Butler, Catherine A. Panozzo, & M. Alan Brookhart. (2018). Rotavirus vaccination and short‐term risk of adverse events in US infants. Paediatric and Perinatal Epidemiology. 32(5). 448–457. 13 indexed citations

14.

Layton, J. Bradley, Anne M. Butler, Dongmei Li, et al.. (2017). Prenatal Tdap immunization and risk of maternal and newborn adverse events. Vaccine. 35(33). 4072–4078. 44 indexed citations

15.

Spoendlin, Julia, et al.. (2016). The Risk of Achilles or Biceps Tendon Rupture in New Statin Users: A Propensity Score-Matched Sequential Cohort Study. Drug Safety. 39(12). 1229–1237. 17 indexed citations

16.

Layton, J. Bradley, Malene Kærslund Hansen, Carl-Johan Jakobsen, et al.. (2015). Statin initiation and acute kidney injury following elective cardiovascular surgery: a population cohort study in Denmark. European Journal of Cardio-Thoracic Surgery. 49(3). 995–1000. 12 indexed citations

17.

Hansen, Malene Kærslund, Henrik Gammelager, Vibeke E. Hjortdal, et al.. (2015). Acute Kidney Injury and Long-term Risk of Cardiovascular Events After Cardiac Surgery: A Population-Based Cohort Study. Journal of Cardiothoracic and Vascular Anesthesia. 29(3). 617–625. 58 indexed citations

18.

Ferris, María, J. Bradley Layton, Michael T Ferris, et al.. (2012). A Clinical Tool to Measure the Components of Health-Care Transition from Pediatric Care to Adult Care: TheUNC TR_xANSITION Scale. Renal Failure. 34(6). 744–753. 131 indexed citations

19.

Layton, J. Bradley, Abhijit V. Kshirsagar, Ross J. Simpson, et al.. (2012). Effect of Statin Use on Acute Kidney Injury Risk Following Coronary Artery Bypass Grafting. The American Journal of Cardiology. 111(6). 823–828. 43 indexed citations

20.

Layton, J. Bradley, et al.. (2009). DIFFUSE ALVEOLAR HEMORRHAGE FOLLOWING PULMONARY THROMBOENDARTERECTOMY IN THE SETTING OF PRIMARY ANTIPHOSPHOLIPID SYNDROME. CHEST Journal. 136(4). 22S–22S. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact